Figure 8: PDAC outcomes and molecular features.
(A-D) Overall (left) and progression free (right) survival in unpaired primaries stratified by TP53 bi-allelic inactivation (A), CDKN2A bi-allelic inactivation (B), hypoxia score (C), or Moffitt expression-based subtyping (D). (E and F) Responses to neoadjuvant chemotherapy, reported as either partial response or stable disease, stratified by hypoxia score (E) or expression-based subtypes (F). See also Tables S4 and S5.